Published in New England Journal of Medicine · View the paper (DOI)
A study found that initial treatment with intravenous immune globulin (IVIG) plus glucocorticoids in children with Multisystem inflammatory syndrome in children (MIS-C) was associated with a lower risk of cardiovascular dysfunction. This is compared to IVIG alone, where left ventricular dysfunction occurred in 17% of patients.
Coverage from 2 institutions
- Study provides MIS-C treatment guidance Louisiana State University Health Sciences Center · Jun 22, 2021 · first to report
- New study may offer treatment guidance for MIS-C Rutgers University · Jul 12, 2021